Ablation Technology Market
Ablation Technology Market Forecasts to 2030 - Global Analysis By Product (Cryoablation Devices, Electrical Ablators, Hydrothermal/Hydromechanical Ablators, Laser/Light Ablators, Microwave Ablators, Radiofrequency Ablators, Ultrasound Ablators and Other Products), Technology (Thermal ablation technology, Non-thermal ablation technology and Other Technologies), Application, End User and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $8.49 BN |
Projected Year Value (2030) |
US $20.85 BN |
CAGR (2023 - 2030) |
13.7% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Ablation Technology Market is accounted for $8.49 billion in 2023 and is expected to reach $20.85 billion by 2030 growing at a CAGR of 13.7% during the forecast period. Ablation usually refers to the surgical removal of a portion of biological tissue. The procedure's devices offer a less intrusive option to traditional surgical treatment for liver, kidney, prostate, and lung cancer. It takes less time to recover because it is a minimally invasive technique and less painful than traditional surgical procedures.
According to an article by RadiologyInfo.org updated in February 2021, radiofrequency ablation (RFA), a minimally invasive treatment for cancer, employs an image-guided technique to apply heat to destroy cancer cells.
Market Dynamics:
Driver:
Hospitals will become a prominent end-user with better patient care
Hospital settings have a significantly higher incidence rate of ablation operations because these facilities guarantee the availability of trained medical professionals and cutting-edge equipment, which reduces the complexity of the procedure. Additionally, market growth will also be aided by the introduction of novel products in the ablation sector and increased government funding for enhancing hospital infrastructure.
Restraint:
High product costs inhibit growth
Depending on the patient's age and severity, the cost of the treatment varies. Catheter ablation will cost approximately 1–1.25 lakh rupees in India. The cost may vary according to the hospital, the surgeon, etc. Eckard et al. estimated the cost of ablation in a decision-analytic model to be about USD 58,000 per quality-adjusted life year. This cost is forecast without assuming that the ablation approach will prevent strokes. Therefore, the worldwide ablation technology market's expansion may be constrained by its expensive price.
Opportunity:
Growing demand for non-invasive and minimally-invasive techniques
Due to the benefits that these procedures offer over conventional treatment methods fewer operative complications, fewer hospital stays, less pain, smaller and more aesthetic incisions, lower risk of infection, reduced post-operative care, and a faster recovery—the demand for minimally invasive procedures has increased significantly. Modern technology is used in minimally invasive procedures to identify and treat diseases like cancer. These techniques are used to remove lymph nodes and cancerous tumors without leaving wounds. Surgeons can also collect samples for biopsies and precise staging tests with the help of minimally invasive procedures.
Threat:
Reusing and processing old technology
Ablation catheters are classified as single-use devices (SUDs) under FDA and EU regulations. Hospitals with limited funds, however, are switching to reprocessing and reuse because of the high per-unit cost and low reimbursement. In comparison to the price of a new ablation device, the cost incurred by a hospital or surgical center for reprocessing and reuse is less than 10%, cutting the whole procedure cost by about 50%. Under the condition that the devices are recycled in accordance with regulatory criteria, Germany is one of the major European nations that permits the reuse of SUDs (including ablation catheters).
Covid-19 Impact:
The COVID-19 epidemic posed significant hurdles for the healthcare sector. Since the majority of chronic therapy was considered non-urgent, all outpatient treatments were delayed or restricted during the COVID-19 pandemic in order to lower the danger of viral transmission. For instance, according to a report published in November 2022 in PubMed, catheter ablation (CA) drastically collapsed in the early stages of the COVID-19 pandemic before gradually recovering to pre-COVID-19 levels. The number of ablation surgeries accomplished during the period is significantly less than that of the prior year due to the COVID-19 pandemic's suspension of all non-urgent elective surgical procedures.
The cancer treatment segment is expected to be the largest during the forecast period
Due to the increasing number of cancer patients worldwide, the Cancer Treatment segment held the largest market share over the projection period. For small tumors, radiofrequency treatment is one of the most popular ablation techniques. Without the need for traditional surgery, special probes are utilized to "burn" or "freeze" tumors. Additionally, the needle probe is guided and positioned into the tumor using magnetic resonance imaging (MRI), ultrasound, or computed tomography (CT). For instance, the IARC predicts that there will be 28.9 million new instances of cancer worldwide by 2040.
The radiofrequency ablators segment is expected to have the highest CAGR during the forecast period
Owing to the increasing use of cutting-edge Radio Frequency (RF) technologies in healthcare as well as the introduction of new products into the market by major market players, the radiofrequency ablators segment is predicted to grow profitably throughout the dominance period. This is driving up demand for radiofrequency ablators. Additionally, when used in combination with a suitable multi-channel RF generator, it is permitted for cardiac ablation and catheter-based cardiac electrophysiology mapping of the atria.
Region with largest share:
Due to improved Research and Development (R&D) for the design of effective ablation products and increasing adoption of new technologies, North America is predicted to hold the largest market share throughout the extrapolated period. Furthermore, the use of more advanced methods and systems in the production of ablation devices, as well as technological developments in ablation device research, are anticipated to drive the market's expansion in the North American region.
Region with highest CAGR:
Due to the increasing prevalence and incidence of cancer and cardiac conditions, technological advancements in ablation products and technology, growing awareness of minimally invasive techniques, and growth opportunities in emerging markets, the Asia-Pacific region commanded lucrative growth during the estimated period. Moreover, the enormous populations affected by chronic diseases and the growing need for ablation devices for rapid identification and treatment of these diseases are also anticipated to fuel the ablation device market's expansion in the region.
Key players in the market
Some of the key players in Ablation Technology market include Johnson & Johnson, Smith & Nephew PLC, Abbott Laboratories, Smith & Nephew plc, Boston Scientific, Olympus Corporation, Medtronic, Varian Medical Systems, AngioDynamics, Inc, Dornier MedTech, AtriCure, Inc. and Alcon Laboratories.
Key Developments:
In October 2022, The C2 CryoBalloon Ablation System was released in Canada to treat Barrett's Esophagus. This was done by PENTAX Medical, a company in the healthcare industry that makes diagnostic and therapeutic endoscopy solutions.
In March 2022, Quantum Surgical received 510(k) clearance from the United States Food and Drug Administration for the Epione robot, which can plan, target, deliver, and confirm tumor ablation for cancer treatment.
In January 2022, Medtronic plc entered into a definitive agreement to acquire Affera, Inc. The acquisition expands the Medtronic portfolio of advanced cardiac ablation products and accessories to meet physician needs within a growing patient population.
In January 2022, Affera, a provider of medical technology, reached a formal agreement under which Medtronic will acquire the company for USD 925 million. Through its portfolio of minority investments, Medtronic has been a strategic investor in Affera and now has a 3% stake in the company.
Products Covered:
• Cryoablation Devices
• Electrical Ablators
• Hydrothermal/Hydromechanical Ablators
• Laser/Light Ablators
• Microwave Ablators
• Radiofrequency Ablators
• Ultrasound Ablators
• Other Products
Technologies Covered:
• Thermal ablation technology
• Non-thermal ablation technology
• Other Technologies
Applications Covered:
• Cardiovascular Disease Treatment
• Cancer Treatment
• Gynecological Treatment
• Cosmetic/ Aesthetic Surgery
• Pain Management
• Orthopedic Treatment
• Urological Treatment
• Ophthalmologic Treatment
• Other Applications
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals and ablation centers
• Medical Spas & Aesthetic clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Ablation Technology Market, By Product
5.1 Introduction
5.2 Cryoablation Devices
5.3 Electrical Ablators
5.4 Hydrothermal/Hydromechanical Ablators
5.5 Laser/Light Ablators
5.6 Microwave Ablators
5.7 Radiofrequency Ablators
5.8 Ultrasound Ablators
5.9 Other Products
6 Global Ablation Technology Market, By Technology
6.1 Introduction
6.2 Thermal ablation Technology
6.2.1 Ultrasound Ablation
6.2.2 Light Ablation
6.2.3 Radiation Ablation
6.2.4 Hydrothermal Ablation
6.2.5 Microwave
6.2.6 Electrical Ablation
6.3 Non-thermal Ablation Technology
6.3.1 Hydromechanical
6.3.2 Cryoablation
6.4 Other Technologies
7 Global Ablation Technology Market, By Application
7.1 Introduction
7.2 Cardiovascular Disease Treatment
7.3 Cancer Treatment
7.4 Gynecological Treatment
7.5 Cosmetic/ Aesthetic Surgery
7.6 Pain Management
7.7 Orthopedic Treatment
7.8 Urological Treatment
7.9 Ophthalmologic Treatment
7.10 Other Applications
8 Global Ablation Technology Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals and Ablation Centers
8.4 Medical Spas & Aesthetic Clinics
8.5 Other End Users
9 Global Ablation Technology Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Johnson & Johnson
11.2 Smith & Nephew PLC
11.3 Abbott Laboratories
11.4 Smith & Nephew plc
11.5 Boston Scientific
11.6 Olympus Corporation
11.7 Medtronic
11.8 Varian Medical Systems
11.9 AngioDynamics, Inc
11.10 Dornier MedTech
11.11 AtriCure, Inc.
11.12 Alcon Laboratories
List of Tables
1 Global Ablation Technology Market Outlook, By Region (2021-2030) ($MN)
2 Global Ablation Technology Market Outlook, By Product (2021-2030) ($MN)
3 Global Ablation Technology Market Outlook, By Cryoablation Devices (2021-2030) ($MN)
4 Global Ablation Technology Market Outlook, By Electrical Ablators (2021-2030) ($MN)
5 Global Ablation Technology Market Outlook, By Hydrothermal/Hydromechanical Ablators (2021-2030) ($MN)
6 Global Ablation Technology Market Outlook, By Laser/Light Ablators (2021-2030) ($MN)
7 Global Ablation Technology Market Outlook, By Microwave Ablators (2021-2030) ($MN)
8 Global Ablation Technology Market Outlook, By Radiofrequency Ablators (2021-2030) ($MN)
9 Global Ablation Technology Market Outlook, By Ultrasound Ablators (2021-2030) ($MN)
10 Global Ablation Technology Market Outlook, By Other Products (2021-2030) ($MN)
11 Global Ablation Technology Market Outlook, By Technology (2021-2030) ($MN)
12 Global Ablation Technology Market Outlook, By Thermal Ablation Technology (2021-2030) ($MN)
13 Global Ablation Technology Market Outlook, By Ultrasound Ablation (2021-2030) ($MN)
14 Global Ablation Technology Market Outlook, By Light Ablation (2021-2030) ($MN)
15 Global Ablation Technology Market Outlook, By Radiation Ablation (2021-2030) ($MN)
16 Global Ablation Technology Market Outlook, By Hydrothermal Ablation (2021-2030) ($MN)
17 Global Ablation Technology Market Outlook, By Microwave (2021-2030) ($MN)
18 Global Ablation Technology Market Outlook, By Electrical ablation (2021-2030) ($MN)
19 Global Ablation Technology Market Outlook, By Non-thermal ablation technology (2021-2030) ($MN)
20 Global Ablation Technology Market Outlook, By Hydromechanical (2021-2030) ($MN)
21 Global Ablation Technology Market Outlook, By Cryoablation (2021-2030) ($MN)
22 Global Ablation Technology Market Outlook, By Other Technologies (2021-2030) ($MN)
23 Global Ablation Technology Market Outlook, By Application (2021-2030) ($MN)
24 Global Ablation Technology Market Outlook, By Cardiovascular Disease Treatment (2021-2030) ($MN)
25 Global Ablation Technology Market Outlook, By Cancer Treatment (2021-2030) ($MN)
26 Global Ablation Technology Market Outlook, By Gynecological Treatment (2021-2030) ($MN)
27 Global Ablation Technology Market Outlook, By Cosmetic/ Aesthetic Surgery (2021-2030) ($MN)
28 Global Ablation Technology Market Outlook, By Pain Management (2021-2030) ($MN)
29 Global Ablation Technology Market Outlook, By Orthopedic Treatment (2021-2030) ($MN)
30 Global Ablation Technology Market Outlook, By Urological Treatment (2021-2030) ($MN)
31 Global Ablation Technology Market Outlook, By Ophthalmologic Treatment (2021-2030) ($MN)
32 Global Ablation Technology Market Outlook, By Other Applications (2021-2030) ($MN)
33 Global Ablation Technology Market Outlook, By End User (2021-2030) ($MN)
34 Global Ablation Technology Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
35 Global Ablation Technology Market Outlook, By Hospitals and Ablation Centers (2021-2030) ($MN)
36 Global Ablation Technology Market Outlook, By Medical Spas & Aesthetic Clinics (2021-2030) ($MN)
37 Global Ablation Technology Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.